Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$2.51B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.53B |
| 3 |
Amazon
AMZN
|
+$1.11B |
| 4 |
Airbnb
ABNB
|
+$574M |
| 5 |
NVIDIA
NVDA
|
+$519M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$588M |
| 2 |
NIO
NIO
|
+$539M |
| 3 |
Apple
AAPL
|
+$525M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$443M |
| 5 |
Microsoft
MSFT
|
+$375M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 90.77% |
| 2 | Consumer Discretionary | 1.94% |
| 3 | Technology | 1.9% |
| 4 | Communication Services | 1.42% |
| 5 | Financials | 1.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8901
Direxion Daily S&P 500 High Beta Bear 3X ETF
HIBS
$19.3M
| $634K | ﹤0.01% |
558
+384
| +221% | +$487K |
|
8902
NNN REIT
NNN
$8.77B
| $634K | ﹤0.01% |
13,522
-43,100
| -76% | -$2.02M |
|
8903
PUT
Vishay Intertechnology
VSH
$4.69B
| $634K | ﹤0.01% |
28,100
+19,100
| +212% | +$458K |
|
|
PRTK
8904
PUT
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $634K | ﹤0.01% |
93,000
+40,000
| +75% | +$323K |
|
8905
PUT
AnaptysBio
ANAB
$1.67B
| $633K | ﹤0.01% |
24,400
-104,100
| -81% | -$2.5M |
|
8906
Corcept Therapeutics
CORT
$12.3B
| $633K | ﹤0.01% |
28,780
+15,195
| +112% | +$338K |
|
8907
CALL
CRA International
CRAI
$1.1B
| $633K | ﹤0.01% |
+7,400
| New | +$602K |
|
8908
Amplify BlackSwan ISWN ETF
ISWN
$37M
| $633K | ﹤0.01% |
25,000
+926
| +4% | +$23.3K |
|
8909
PUT
Freedom Holding
FRHC
$11.2B
| $632K | ﹤0.01% |
+9,700
| New | +$513K |
|
|
GOOD
8910
CALL
Gladstone Commercial Corp
GOOD
$630M
| $632K | ﹤0.01% |
+28,000
| New | +$598K |
|
8911
Vanguard S&P Mid-Cap 400 Growth ETF
IVOG
$1.66B
| $632K | ﹤0.01% |
6,302
-25,212
| -80% | -$2.51M |
|
|
MORF
8912
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $632K | ﹤0.01% |
+11,018
| New | +$606K |
|
8913
Genprex
GNPX
$3.01M
| $631K | ﹤0.01% |
4
-3
| -43% | -$492K |
|
8914
Gossamer Bio
GOSS
$83.2M
| $631K | ﹤0.01% |
77,671
+10,506
| +16% | +$91.1K |
|
8915
PUT
Hess Midstream
HESM
$5.08B
| $631K | ﹤0.01% |
25,000
-23,600
| -49% | -$570K |
|
8916
System1
SST
$16.5M
| $631K | ﹤0.01% |
6,371
+2,169
| +52% | +$216K |
|
|
GTT
8917
CALL
DELISTED
GTT Communications, Inc.
GTT
| $631K | ﹤0.01% |
259,800
+240,200
| +1,226% | +$466K |
|
8918
FreightCar America
RAIL
$235M
| $630K | ﹤0.01% |
+106,243
| New | +$646K |
|
8919
Invesco S&P MidCap 400 Revenue ETF
RWK
$1.34B
| $630K | ﹤0.01% |
+7,120
| New | +$638K |
|
8920
PUT
Steven Madden
SHOO
$3.24B
| $630K | ﹤0.01% |
+14,400
| New | +$594K |
|
|
XIN
8921
CALL
DELISTED
Xinyuan Real Estate
XIN
| $630K | ﹤0.01% |
23,760
+6,650
| +39% | +$171K |
|
|
WBT
8922
PUT
DELISTED
Welbilt, Inc.
WBT
| $630K | ﹤0.01% |
27,200
-20,200
| -43% | -$429K |
|
8923
AngioDynamics
ANGO
$655M
| $629K | ﹤0.01% |
23,175
-19,554
| -46% | -$478K |
|
8924
CALL
Dorchester Minerals
DMLP
$1.41B
| $629K | ﹤0.01% |
37,300
+11,600
| +45% | +$177K |
|
8925
CALL
RLX Technology
RLX
$2.24B
| $629K | ﹤0.01% |
72,000
-274,300
| -79% | -$2.8M |
|
Similar funds
Jeff Yass's Q2 2021 Portfolio in Review
As of Q2 2021, Jeff Yass held 13,792 positions worth $712B, up 12% from $634B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jeff Yass's Q2 2021 filing shows 1,607 new, 5,174 increased, 5,388 reduced and 1,330 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 622,837 shares worth $103M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $588M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 91% a quarter earlier, followed by Consumer Discretionary and Technology.
- Jeff Yass's largest Q2 2021 buy was PRA Health Sciences, Inc.: 622,837 shares worth $103M.
- Jeff Yass added most to Walt Disney in Q2 2021, an estimated $2.51B increase.
- Jeff Yass's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $588M.
- Jeff Yass fully exited iShares Core MSCI EAFE ETF in Q2 2021, selling an estimated $59.3M.
- Jeff Yass's ten largest holdings make up 30% of its $712B portfolio in Q2 2021.
- Jeff Yass opened 1,607 new positions and closed 1,330 in Q2 2021.
- Jeff Yass's portfolio value rose 12% quarter-over-quarter to $712B.
Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.